Founded in 2018, VitaNav is a life sciences company developing energy and neurohealth compounds, centered on D-beta hydroxybutyrate (D-BHB) made through a proprietary carbon-negative bio-fermentation process using renewable plant sugars. Its first D-BHB patent was granted in 2021, and the company launched Kenetik as a direct-to-consumer ketone energy product later that year while continuing related medical and research studies.
Diabetes4LivingFounded in 2018 by pharmaceutical and consumer-products executive Gary April, Diabetes4Living develops nutritional supplements for people with diabetes, beginning with its BetiVite daily multivitamin. The company’s formulas are science-based and designed around diabetic nutritional needs, with ingredients such as added sugar, sodium and artificial dyes removed. April brings more than 25 years of industry experience, including launching a branded over-the-counter diabetic-products division before creating Diabetes4Living.
Healthvine Pharma LLCHealthvine Pharma LLC develops and manufactures medicines, devices, and wellness products, including its pharmacist-formulated VitaComp Energy+Vitamins supplement. Founded in 2015, the company produces in FDA-inspected U.S. facilities using processes compliant with Good Manufacturing Practices and subjects each product to detailed quality checks. Its focus is on combining pharmaceutical research with nature-based ingredients to support everyday health and vitality.423450COLLEGEVILLE, PA
Neuropathix, IncFounded in 2010 through the creation of Kannalife Sciences, Neuropathix develops synthetic CBD-inspired therapeutics for neuroinflammation, neuropathic pain and neurodegenerative disease. Its lead compound, KLS-13019, is a globally patented non-opioid candidate being advanced from preclinical and IND-enabling research for chemotherapy-induced peripheral neuropathy, with research conducted at the Pennsylvania Biotechnology Center in Doylestown. The company’s scientific team brings more than 75 years of pharmaceutical research experience and holds more than 65 patents jointly.DOYLESTOWN, PA
Kannalife Sciences, IncFounded in 2010 and based at the Pennsylvania Biotechnology Center in Doylestown, Kannalife Sciences develops patented synthetic CBD-inspired therapeutics for neuroinflammation, neuropathic pain and neurodegenerative disease. Its lead investigational molecule, KLS-13019, is being advanced as a potential non-opioid treatment for chemotherapy-induced peripheral neuropathy, with research also examining Parkinson’s disease and other conditions linked to oxidative stress. Kannalife is a wholly owned Neuropathix subsidiary whose scientific team reports more than 75 years of combined pharmaceutical research experience and over 65 jointly held patents.DOYLESTOWN, PA